Ramy Farid
Director · Vir Biotechnology, Inc.
- 2026
- May 28, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ramy Farid files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Endurance (Cayman) Ltd - $9.98M in VIR purchases and sales in the last 12 months
- Vicki L. Sato - $1.47M in VIR purchases and sales in the last 12 months
- Karen Akinsanya - $972K in SDGR purchases and sales in the last 12 months
- Backer Marianne de - $947K in VIR purchases and sales in the last 12 months
- Verneuil Vanina de - $218K in VIR purchases and sales in the last 12 months
- Brent Sabatini - $113K in VIR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ramy Farid?
Ramy Farid is a corporate insider, tracked as Director of Vir Biotechnology, Inc. (VIR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ramy Farid last file a Form 4?
The most recent primary Form 4 on record is dated 28 May 2026, one of 4 filings going back to 2026.
Has Ramy Farid been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.17M) across all tracked filings.
